Logo

Broad Institute to Use Affy s 500K Arrays in Large-Scale Genotyping Study

Jul 21, 2005

NEW YORK, July 21 (GenomeWeb News) - The Broad Institute will use Affymetrix's genotyping arrays to conduct whole-genome association studies looking into the genetic causes of cancer, cardiovascular, metabolic, and neuropsychiatric diseases, the company said today.

 

Institute researchers and their collaborators in academia and industry plan to use Affy's GeneChip Mapping 500K arrays to analyze 12,000 human DNA samples, generating more than 6 billion genotypes. They also plan to develop new laboratory and analysis methods for the arrays, which they will use under an early access program.

 

Affymetrix said it expects to launch the 500K arrays commercially later this year.

Breaking News
The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.